Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Mills-Peninsula, San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The CONVERGE-PAS trial aims to assess the safety and efficacy of a hybrid convergent approach combining epicardial and endocardial radiofrequency ablation for the treatment of symptomatic longstanding persistent atrial fibrillation (AF). The trial aims to offer improved treatment options for this at-risk population, addressing the unique challenges of managing longstanding persistent AF.
Location: CPMC (San Francisco), Mills (Peninsula) and ABSMC (Alta Bates).
Please contact: Milena.Ferreira@sutterhealth.org about study CONVERGE PAS (AtriCure)
Principal Investigator
Christopher Woods, M.D., Ph.D., FHRS